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Enterococcus faecalis has been suggested to be 
an important etiological agent in endodontic fail- 
ures. The purpose of this study was to evaluate the 
effectiveness of chlorhexidine- or antibiotics- 
based medications in eliminating €. faecalis bio- 
films. One-day and three-day biofilms of E. faecalis 
were induced on cellulose nitrate membrane fil- 
ters. Each biofilm-containing membrane was thor- 
oughly covered with 1 ml of the test medications 
and incubated for 1 day at 37°C. Treated biofilms 
were then aseptically transferred to vials contain- 
ing a neutralizing agent in saline solution and vor- 
texed. Suspensions were 1 0-fold diluted, seeded 
onto Mitis salivarius agar plates, and the colony- 
forming units counted after 48 h of incubation. 
There were significant differences between the for- 
mulations tested. The association of clindamycin 
with metronidazole significantly reduced the num- 
ber of cells in 1-day biofilms. However of all med- 
ications tested, only 2% chlorhexidine-containing 
medications were able to thoroughly eliminate 
most of both 1-day and 3-day E. faecalis biofilms. 
Enterococci are involved in a wide variety of infections in humans, 
including infections in the urinary tract, bloodstream, endocar- 
dium, abdomen, biliary tract, bum wounds, and indwelling foreign 
devices (such as intravascular catheters). They have also become 
established as a nosocomial pathogen (1, 2). 
Although enterococci are not normally present or are present in 
very low numbers in untreated root canals (3, 4), they have been 
suggested to be important agents in endodontic failure. Molander 
et al. (5 )  examined the microbiological status of root filled teeth 
with periradicular lesions and found enterococci in 32% of the 
investigated teeth. Under similar conditions Moller (6)  and 
Sundqvist et al. (7) isolated Enterococcus faecalis from 29% and 
38% of canals that had recoverable microorganisms, respectively. 
It has been reported that infections by enterococci can be dif- 
ficult to treat (8, 9). Enterococci show intrinsic and acquired 
resistances to several antibiotics. They are intrinsically resistant to 
practically all available cephalosporins and have reduced sensitiv- 
ity to penicillins, carbapenems and other p-lactams. Enterococci 
are also unsusceptible to aminoglycosides. In addition to intrinsic 
resistances enterococci have acquired genetic determinants that 
confer resistance to all classes of antimicrobials, including chlor- 
amphenicol, tetracyclines, macrolides, and clindamycin (1, 8). 
Studies have also revealed that calcium hydroxide dressing is 
ineffective against enterococci (3, 10-12). Therefore it seems that 
the frequent isolation of enterococci in failed endodontic cases puts 
in question the routine use of calcium hydroxide as an intracanal 
medication (5). 
Recognizing the potential role of E.faecalis in the failure of root 
canal therapy makes it important to develop strategies to control 
infections caused by this organism. Thus the purpose of this study 
was to evaluate the effectiveness of alternative medications in 
eliminating E. faecalis biofilms. 
MATERIALS AND METHODS 
Biofim Formation 
Biofilms of E. faecalis strain ATCC 29212 were induced on 
cellulose nitrate membrane filters. An aliquot of 20 p1 of an 
overnight culture of E. faecalis grown in brain heart infusion broth 
(Difco, Detroit, MI) was seeded onto 13.0 mm diameter cellulose 
nitrate membrane filters (0.22 p m  pore diameter; Whatman Ltd., 
Maidstone, Kent, UK), which were on the surfaces of Mitis sali- 
varius agar (Difco) plates. Inoculum was standardized to 0.08 to 
0.10 at 625 nm of wavelength. Nine membranes were used for each 
plate. Plates containing membranes were then incubated for either 
1 day or 3 days at 37°C in an aerobic atmosphere. The method used 
herein was modified from that described by Thrower et al. (13). 
Antimicrobial Medications Tested 
The medications tested were in gel form. They were as follows: 
a. 2% gluconate chlorhexidine, 2% natrozole, in distilled water 
b. 2% gluconate chlorhexidine, 1.25% lauryl-diethylene-gly- 
col-ether-sodium sulfate, 2% natrozole, in distilled water 
c. 2% clindamycin, 2% natrozole, in distilled water 
d. 2% clindamycin, 1.25% lauryl-diethylene-glycol-ether-so- 
dium sulfate, 2% natrozole, in distilled water 
e. 2% gluconate chlorhexidine, 15% zinc oxide, 1.25% lauryl- 
diethylene-glycol-ether-sodium sulfate, 2% natrozole, in dis- 
tilled water 
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TABLE 1. No. of viable bacterial cells in 1-day E. faeca/js biofilms after exposure to the test medications (in log units) 
Specimen Adhered 
(n = 6) Cells* a 
Medicationst 
b c d e f 
Control 
1 7.74 2.84 0 7.47 6.14 0 6.53 6.19 
2 8.53 2.69 0 7.99 6.93 1.77 7.33 6.98 
3 6.60 0 1.30 7.33 6.89 0 5.47 6.99 
4 6.68 0 0 8.50 7.10 1.23 4.78 8.24 
5 7.00 0 0 8.31 6.23 0 6.75 6.84 
6 6.1 7 0 0 8.49 6.53 0 6.47 7.34 
Mean t SD 7.12 2 0.87 0.92 2 1.43 0.22 2 0.53 8.02 t 0.51 6.64 t 0.40 0.50 t 0.79 6.22 2 0.93 7.10 2 0.68 
. No. of adhered cells in biofilms afler the time of medication exposure. 
t Medications in gel form (natrozole): (a) 2% chlorhexidine: (b) 2% chlorhexidine and detergent: (c) 2% clindamycin; (d) 2% clindamycin and detergent; (e) 2% chlorhexidine, 15% zinc 
oxide. and detergent; (0 2% clindamycin, 10% metronidazole. and detergent; and (control) detergent. 
f. 2% clindamycin. 10% metronidazole, 1.25% lauryl-diethyl- 
ene-glycol-ether-sodium sulfate, 2% natrozole, in distilled 
water. 
The control group consisted of a gel compound containing 2% 
natrozole and 1.25% lauryl-diethylene-glycol-ether-sodium sulfate 
in distilled water. 
Biofilm Susceptibility Assay 
Each biofilm-containing membrane was thoroughly covered 
with 1 ml of the test medications and incubated for 1 day at 37°C. 
Uncovered biofilm membranes served as a control of adhered and 
lost cells before and after the application of test medications. Six 
biofilm membranes were used for each group, including the con- 
trols. 
At the day of medication application control membranes con- 
taining untreated biofilms were transferred to vials containing 10 
ml of sterile saline solution and maintained immersed for 1 min 
under light agitation to recover microorganisms not adhered. Af- 
terward each membrane was transferred to another vial containing 
10 ml of saline solution and vigorously vortexed for 1 min to 
suspend adhered cells. The same procedure was performed for 
other control membranes after 1 day, which corresponded to the 
time of medication application. The obtained suspensions were 
10-fold diluted in 0.85% saline solution and the viable cells were 
counted on Mitis snlivarius agar after aerobic incubation for 48 h 
at 37°C. 
Treated biofilms were then aseptically transferred to vials con- 
taining 10 ml of saline solution with Letheen broth (neutralizing 
broth) and vortexed for 1 min. Suspensions were 10-fold diluted, 
seeded onto Mitis salivarius agar plates and the colony-forming 
units (CFU) counted after 48 h of aerobic incubation at 37°C. 
The same procedures were performed for I-day and 3-day 
biofilms. However only medications a, b, and e were tested against 
the 3-day biofilms. 
Statistical Analysis 
To confer homoscedasticity to the populations, data concerning 
CFU counts were transformed in log numbers. Student’s t test was 
used to compare data obtained from untreated biofilms (control 
group) taken at the day of medication application and after one 
more day, as well as the number of adhered and lost cells in each 
period. Data concerning medication effectiveness against biofilms 
were analyzed for differences using ANOVA and Tukey’s test. 
The significance level was always established in 5% (p < 0.05). 
RESULTS 
Controls 
No significant difference was observed between the mean num- 
bers of adhered and lost cells in I-day biofilms that were 7.28 and 
7.38 (in log units), respectively. Conversely there was a significant 
loss of cells in 3-day biofilms. The mean numbers of adhered and 
lost cells in 3-day biofilms were 7.41 and 8.13, respectively. 
After an additional day (corresponding to the time of medication 
exposure) untreated 1 -day. biofilms (control) showed no differ- 
ences between adhered and lost cell numbers (7.12 and 8 log units, 
respectively). Again a significant loss of cells was observed for the 
3-day biofilms (adhered cells = 6.47 and lost cells = 8.1 I ) .  
No differences were found when comparing the number of 
adhered cells in control 1 -day biofilms immediately before the time 
of medication application (7.28 CFU) and after one more day (7.12 
CFU). The same results were observed when comparing the num- 
ber of lost cells before and after the time of medication exposure 
(7.38 and 8, respectively). 
Regarding the controls of 3-day biofilms, the number of adhered 
cells before medication application was significantly higher when 
compared with the number of adhered cells after the time corre- 
sponding to medication application (7.41 and 6.47, respectively). 
However no difference was observed regarding the number of 
detached cells (before = 8.13 and after medication application = 
8.1 I ) .  
Significant differences were also observed when comparing the 
number of adhered cells in I-day and 3-day biofilms after the time 
corresponding to medication application. 
Biofilms that were in contact with the control medication (natro- 
zole plus lauryl-diethylene-glycol-ether-sodium sulfate) showed 
no significant cell loss (7.10 CFU) when compared with the num- 
ber of adhered cells in the I-day biofilm (7.12 CFU). 
Susceptibilities of 1- and 3-Day Biofilms 
Results of the effects of the test medications on the I-day 
biofilms are shown in Table 1. There were significant differences 
between the medications tested. Medications a, b, e. and f signif- 
icantly reduced the number of viable bacterial cells in the biofilms. 
However only the chlorhexidine-containing medications (a, b, and 
e) were able to completely eliminate most of the biofilms. Medi- 
cation d and the control medication did not significantly affect the 
biofilm. Medication c allowed the overgrowth of bacteria. 
When comparing the test formulations, it was verified that pairs 
de ,  ble, d f ,  and dcontrol medication showed no differences re- 
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TABLE 2. No. of viable bacterial cells in 3-day E. faecalis 
biofilms after exposure to 2% chlorhexidine-containing 
medications (in log units) 
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incubation. Our findings suggested that 3-day biofilms can be 
difficult to use in evaluating antimicrobial activity of medications 
once the number of lost cells is relatively high. However although 
3-day biofilms show a smaller number of adhered cells when 
compared with 1-day biofilms, they are usually more mature and 
theoretically more difficult to eliminate, justifying their use in the 
present investigation. 
The association of clindamycin with metronidazole significantly 
reduced the number of cells in 1-day biofilms. However of all 
medications tested, only chiorhexidine-containing formulations 
were able to thoroughly eliminate both I-day and 3-day E.fueculis 
biofilms. Chlorhexidine is used worldwide in dental plaque control 
and recently has been suggested as an intracanal medication. Al- 
though the occurrence of chlorhexidine-resistant enteric strains has 
been reported (15), the findings of the present study are in agree- 
ment with others when evaluating the effects of chlorhexidine 
against enterococci (17, 18). 
Studies have revealed that chlorhexidine has significant anti- 
bacterial activities against most of the bacterial species isolated 
from infected root canals (18-20). Chlorhexidine is a cationic 
molecule that exerts its antibacterial effects by disrupting the 
integrity of the bacterial cytoplasmic membrane, causing leakage 
of intracellular contents (1 8). In higher concentrations the precip- 
itation of the bacterial cytoplasm occurs as result of the interaction 
between chlorhexidine and phosphated entities, such as adenosine 
triphosphate and nucleic acids (18). 
The medications tested were in gel form (natrozole) to make 
application in the root canal system easier. In addition they may 
possibly be retained in the root canal for longer periods. Because 
the anionic detergent used in some formulations (lauryl-diethyl- 
ene-glycol-ether-sodium sulfate) has a low surface tension, it could 
theoretically enhance the effectiveness of the medications on the 
biofilms. On the other hand an anionic detergent can theoretically 
dampen the antimicrobial effects of chlorhexidine, which is a 
cationic substance. In any event our findings demonstrated that this 
detergent did not significantly affect the effectiveness of the med- 
ications (particularly chlorhexidine) on E. fueculis biofilms. 
The results of this study indicated that chlorhexidine may exert 
an important role in the eradication of endodontic infection asso- 
ciated with teeth that were refractory to the conventional endodon- 
tic therapy. Further clinical studies may help to c o n f m  our find- 
ings. 
Medicationst 
Adhered Cells' Specimens 
(n = 6) a b e 
1 5.3 0 0 1 .a4 
2 5.3 0 2 4.72 
3 6.77 0 4.1 0 
4 6.77 0 0 0 
5 7.34 0 1.84 0 
6 7.34 0 1.3 0 
Mean 2 SD 6.47 t 0.94 0 t 0 1.54 t 1.53 1.09 ? 1.92 
* No. of adhered cells in biofilms after the time of m e d i a t i  exposure. 
t Medications in gel form (natrozole): (a) 2% chlorhexidine; (b) 2% chlorhexidine and 
detergent: and (e) 2% chlorhexidine. 15% zinc oxide, and detergent. 
garding antibacterial activity. Significant differences were ob- 
served when comparing the other pairs. 
Because of the results of I-day biofilms, only medications a, b, 
and e were tested against 3-day biofilms. Results are shown in 
Table 2. All medications were effective in eliminating or at least 
inducing a significant reduction of the bacterial cell number in the 
biofilms. There were no significant differences between medica- 
tions (p > 0.05). 
DISCUSSION 
Enterococci are normal commensals adapted to the nutrient- 
enriched, oxygen-depleted, ecologically complex environments of 
the oral cavity, gastrointestinal tract, and vaginal vault. During 
tissue invasion enterococci usually encounter adverse environmen- 
tal conditions, including limited nutrients availability and host 
defense molecules and cells. To cause an infection enterococci 
likely express genes favoring survival under these adverse tissue 
conditions (2). 
Definite and potential virulence factors for E. fueculis include 
cytolysin (lytic toward selected mammalian cells), aggregation 
substance (involved in binding to host cells), pheromones (che- 
moattractant for neutrophils), lipoteichoic acid (stimulates cyto- 
kine production by monocytes), and lytic enzymes, such as pro- 
tease (gelatinase) and hyaluronidase (2). The cell arrangement in 
biofilms may also be important in the infectivity of this microor- 
ganism. 
E. faecalis has been recovered from several oral sites (14). It 
was selected for use in this study because it exhibits a high level 
of resistance to a wide range of antimicrobial agents (1,8, 15), and 
it is among the few facultative bacteria associated with persistent 
apical periodontitis (5-7, 9, 16). Endodontic infections with E. 
fueculis usually constitute a problem in treatment because this 
microorganism is difficult to eliminate (9). 
The method used herein was useful to induce in vitro biofilm 
formation. No difference was observed between adhered and lost 
cells when examining 1-day biofilms. The same finding was ver- 
ified after one more day of incubation, which simulated the expo- 
sure time of the medications tested. These findings indicated that 
I-day E. fueculis biofilms may be effectively used to compare the 
antimicrobial effectiveness of medications. On the other hand 
3-day biofilms showed significantly more lost bacterial cells than 
adhered cells. The same finding was observed after one more day 
of incubation. The number of adhered cells before medication 
application was also significantly higher than after one more day of 
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